Zeskind Benjamin J. 4
4 · Immuneering Corp · Filed Feb 14, 2022
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option
2022-02-10+156,485→ 156,485 totalExercise: $9.66Exp: 2032-02-09→ Class A Common Stock (156,485 underlying) - Award
Stock Option
2022-02-10+45,615→ 202,100 totalExercise: $10.63Exp: 2027-02-09→ Class A Common Stock (45,615 underlying)
Footnotes (2)
- [F1]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.
- [F2]The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.